Veriheal

NOVEMBER 24, 2021

For the first time ever, researchers will conduct a comprehensive state population health analysis to understand the impact of medical cannabis on consumers’ healthcare —and it’s all happening in Arkansas. A Deep Dive Into Cannabis Consumer Data. To fund the study, a $1.3 Hudson, Ph.D.,

Programs 98

Programs Research and Development Data Dispensary 98

Veriheal

JANUARY 16, 2024

Let’s take a closer look at this new research around CBD for Cerebral Palsy and examine the extent of this trend and its implications for the future of CP management. It occurs due to abnormalities or damage to the developing brain before, during, or after birth. What is Cerebral Palsy?

Patients 113

Patients CBD Treatment Research and Development 113

NewsMunchies

JULY 10, 2023

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis research problem. What makes a good research study, anyway?

Research and Development 112

Research and Development Data THC Clinical Trials 112

Veriheal

SEPTEMBER 30, 2021

Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Additionally, the increase in the availability of cannabis research has led to a decrease in stigmatization attached to cannabis.

Patients 98

Patients Research and Development Treatment Consumption 98

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. Declining circulating tumor cell (CTC) count in treated patients.

Data 100

Data Research and Development Clinical Trials Therapy 100

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. Anonymized data also helps scientists better understand the cannabis plant and what products and chemical profiles are most effective for treating different conditions and symptoms.

Data 104

Data Research and Development Patients Strains 104

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

DECEMBER 27, 2019

A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Clinical trials are medical research projects involving human participants.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.

Patients 89

Patients Clinical Trials Research and Development Treatment 89

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Veriheal

JANUARY 10, 2022

Enter cannabis, the plant medicine that is quickly becoming the remedy of choice for patients who have been diagnosed with breast cancer according to a recently conducted survey that was published in the journal Cancer. Breast Cancer Patients and Medical Cannabis. More cancer patients in the U.S. Over 600 Study Participants .

Patients 98

Patients Treatment Medicine Consumption 98

Veriheal

NOVEMBER 13, 2020

Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). Many patients with OCD tend to perform actions without wanting to, but feeling powerless to try and stop it. What Does Research Say About Cannabis and OCD?

Research and Development 98

Research and Development Consumption Patients Strains 98

Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

JULY 29, 2021

Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question. There have been various individual studies of the condition, but the Ehave study could be the largest patient study to date. Some people have different flashback experience.

Research and Development 105

Research and Development Conditions Data Patients 105

Cannabis Law Report

JUNE 19, 2022

Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. This latest partnership further strengthens Beckley Psytech’s digital strategy to develop personalised, end-to-end treatment programmes for patients in areas of significant unmet medical need.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. MYMD-1 is being developed to treat autoimmune and age-related diseases, and to slow aging thereby increasing life-span. Acumen Research and Consulting confirmed TNF-? President, Director and Chief Medical Officer of MyMD.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. cannabis researchers. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis.

DEA 52

DEA Research and Development Data Cannabis 52

Cannabis Law Report

SEPTEMBER 23, 2021

BIMA was an Open-label safety, tolerability and proof-of-concept study to investigate the role of MDMA-Assisted Psychotherapy in treating patients with alcohol use disorder (AUD). This data will assist Awakn’s progress by enabling a better design and more efficient execution of its clinical program.

Research and Development 52

Research and Development Therapy Treatment Data 52

United Patients Group

JANUARY 4, 2024

As we move forward into 2024 and beyond, the sector offers diverse paths beyond direct patient care. The growth stems from rising healthcare demand, facility expansion, and the imperative for efficient administration to maintain quality patient care. Adverse drug events (ADEs) affect approximately 7 per 100 hospitalized patients.

Research and Development 52

Research and Development Patients Data Policy 52

SpeedWeed

JULY 7, 2021

Luisa Conesa, an attorney and cannabis activist, told Reuters of the medical regulations: “[The regulation] is not aimed at patients growing their own cannabis, it is aimed at pharmaceutical companies producing pharmaceutical derivatives of cannabis which are classified as controlled substances that need prescription.”. View original article.

Research and Development 52

Research and Development Pharmaceutical Cannabinoids Supply Chain 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Big Data Improves Distribution in the Marijuana Industry. Source: [link]. Global Cannabis Applications Corp.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

AUGUST 3, 2021

Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Data Bridge sees strong psychedelics growth.

Research and Development 105

Research and Development Data Conditions Therapy 105

Veriheal

NOVEMBER 21, 2023

Scientific research supports the potential of cannabinoids in regulating blood sugar levels, weight management, and addressing diabetic neuropathy. Quemarr’s transformative approach to diabetes treatment offers patients a less intrusive alternative to conventional insulin treatments.

Research and Development 108

Research and Development Consumption Education Data 108

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 Formula 1 THC is higher than CBD.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Veriheal

FEBRUARY 9, 2023

Now, Australian researchers think they may have found an answer: taking psilocybin before MRIs. While comfy MRIs are not its primary goal, this psychedelic research has provided solid preliminary evidence that the psychoactive compound found in magic mushrooms can help accomplish just that.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Cannabis Law Report

NOVEMBER 10, 2021

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS IND-enabling studies for Envelta are being performed under a Cooperative Research and Development Agreement (CRADA) with NCATS entered into by Virpax in August of 2020. “We

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Moreover, ensuring product quality and safety throughout the supply chain is paramount to maintain patient trust and regulatory compliance.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Veriheal

FEBRUARY 18, 2021

But it’s acknowledged that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. The university has conducted research that studied the best music to include in psychedelic therapy. Johns Hopkins Explored Which Music Genres Work Best.

Therapy 52

Therapy Research and Development Collective Consumption 52

Project CBD

JANUARY 24, 2019

Published in Nature , the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD -rich oil derived from cannabis (30% CBD , 1-2% THC ). Previous research has found that THC may be effective for some cases that do not respond well to Ritalin. .

Research and Development 252

Research and Development Chronic Pain Cannabinoids Treatment 252